Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 3/20 | 0.46 |
| ▸ | CDC25A | P30304 | 6/20 | 0.43 |
| ▸ | CDC25B | P30305 | 6/20 | 0.43 |
| ▸ | CDC25C | P30307 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | IAPP | P10997 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11774947 | 0.89 | MAPT (0.50) | EPHX2ELANECDC25ACDC25BCDC25C | |
| SCHEMBL968257 | 0.87 | MAPT (0.47) | EPHX2ELANECDC25ACDC25BCDC25C | |
| SCHEMBL5311171 | 0.87 | MAPT (0.47) | EPHX2ELANECDC25ACDC25BCDC25C | |
| SCHEMBL26218811 | 0.85 | MEN1 (0.44) | ELANEMAPTKMT2ACES2CES1 | |
| SCHEMBL11322723 | 0.82 | CTRC (0.49) | EPHX2MAPTALDH1A1 | |
| Viridepyronone SCHEMBL18270619 | 0.78 | ALDH1A1 (0.40) | EPHX2MAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL5670146 | 0.76 | EPHX2 (0.64) | EPHX2ELANEMAPTCES2CES1 | |
| SCHEMBL3506260 | 0.73 | EPHX2 (0.83) | EPHX2MAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL2703694 | 0.73 | EPHX2 (0.83) | EPHX2MAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL14054041 | 0.73 | EPHX2 (0.83) | EPHX2MAPTKMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3292132-B1 | PI3K INHIBITOR COMPOUNDS TO TREAT CANCER | FUNDACION MEDINA CENTRO DE EXCELENCIA EN INVESTIG DE MEDICAMENTOS INNOVADORES EN ANDALUCIA (ES) | 2019-05-22 | — | — | EP | disclosed |